A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for repurposing in dementia prevention.

NATIONWIDE — The distributor of a variety of losartan, a popular blood pressure medication, has expanded the drug's recall over concerns it contains more than the acceptable trace amount of a ...

Check your medication: Here's how to see if your blood pressure meds are recalled over possible cancer risk Various versions of valsartan, losartan and irbesartan drugs have been part of the recalls.

Our results suggest that losartan was well tolerated by children with RDEB, and provide preliminary evidence that it may reduce disease burden. Further research with larger sample sizes and longer ...

Banerjee, S. and Pathan, A. (2024) Losartan Induced Angioedema, a Rare Case Report and the Dilemma of Using Angiotensin II Receptor Blockers in Patients with Previous Angioedema with Angiotensin ...

Researchers from the University of Missouri School of Medicine are using losartan in a new gene therapy that makes cancer cells more sensitive to the effects of chemo.

The trial’s investigators have now identified potential mechanisms behind the treatment’s beneficial effects. The combination therapy — losartan+FFX+CRT — includes the blood pressure drug losartan ...

To optimize losartan administration, addressing both the drugs’ short half-life, and localization of the drug will improve regenerative function. One approach to generating local and sustained release ...

New research led by investigators at Massachusetts General Hospital (MGH) reveals that the blood pressure drug losartan can prevent immunotherapy-induced edema.

Aerobic exercise increases the effectiveness of the drug losartan for patients with high blood pressure, in particular improving autonomic regulation of the heart and contributing to proper ...

Efficacy and Safety of Chinese Herbal Medicine Compared With Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial In the article by Lai et al, ...